Notícias e Atividades da ASP Isotopes

ASP Isotopes é uma empresa listada sob o símbolo ASPI (US).

Veja o organograma con seus 12 executivos principais

Biografias mais buscadas da ASP Isotopes

• Paul Mann, Chairman of the Board and Chief Executive Officer
• Einar Ronander, Non-Executive Director
• Sipho Maseko, Director

Recentes movimentos de executivos em ASP Isotopes

• Sipho Maseko, ingressou na Companhia como Director  (Notícia publicada em 15 de abril de 2025).

Criar um alerta
para seguir os movimentos de executivos da ASP Isotopes.

ASP Isotopes possui 1.020 concorrentes concorrentes Philips (Holanda), Medtronic (Irlanda) e Thermo Fisher Scientific (Estados Unidos).

Popular M&A news in Equipamentos Médicos

• Globus Medical has announced the acquisition of Nevro  (publicado em 4 de abril de 2025).
• Amboss acaba de anunciar uma arrecadação de fundos de 259 milhões de dólares. (publicado em 3 de abril de 2025).
• Patricia Industries has announced the acquisition of Nova Biomedical  (publicado em 24 de março de 2025).

Outros contatos sugeridos na indústria do Equipamentos Médicos

• Volker Wetekam - Director da Elekta Instrument
• Andrew Elbardissi - Director da Medical Microinstruments
• Marc Casper - Chairman of the Board, President and Chief Executive Officer da Thermo Fisher Scientific

Saiba mais sobre a indústria do Equipamentos Médicos

Últimos comunicados de imprensa de ASP Isotopes

• ASP Isotopes Inc. Hosts Investor Access Event in South Africa Providing Updates on its Silicon-28, Ytterbium-176 and Carbon-14 Facilities
• ASP Isotopes Issues Letter to Shareholders
• ASP Isotopes Inc. Responds To Short Seller “Report”
• ASP Isotopes Inc. to host Investor Access Event in South Africa from January 14-16, 2025
• ASP Isotopes Inc. Responds to Short Seller Report
• ASP Isotopes Inc. Completes Construction and Starts the Commissioning of Silicon-28 Enrichment Facility
• ASP Isotopes Inc. enters into Memorandum of Understanding with the South African Nuclear Energy Corporation (Necsa) to collaborate on the research, development and construction of an Advanced Nuclear Fuel Production Facility
• ASP Isotopes Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares
• ASP Isotopes Inc. Enriches Ytterbium-176 During Commissioning Phase of First Quantum Enrichment Facility and Expects to Offer Highly Enriched Ytterbium-176 for Commercial Sale in 2025
• ASP Isotopes Inc. Completes Construction Phase of Ytterbium-176 Enrichment Facility
• View more press releases Close

Redes sociais sobre ASP Isotopes

• ASP Isotopes na Wikipedia, Google News e Yahoo Finance
• ASP Isotopes na LinkedIn, Twitter e YouTube